Fresenius Medical Care AG (MEX:FME N) DeferredTaxAndRevenue: MXN0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FME N Fresenius Medical Care AG MEX:FME N
48 GF Score
Price MXN778.14
GF Value MXN1,670.07
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG DeferredTaxAndRevenue?

Fresenius Medical Care AG MEX:FME N 48 DeferredTaxAndRevenue is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:FME N with a GF Score™ of 48/100 and a GF Value™ of MXN1,670.07 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Fresenius Medical Care AG's current deferred tax and revenue for the quarter that ended in Mar. 2026 was MXN0 Mil.

Fresenius Medical Care AG DeferredTaxAndRevenue Related Terms

Fresenius Medical Care AG DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG DeferredTaxAndRevenue Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,007.78 2,183.41 1,588.56 1,794.36 2,411.27

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2,411.27 0.00
MEX:FME N
48GF Score
Fresenius Medical Care AG MEX:FME N
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of MXN0 Mil mean?
Fresenius Medical Care AG (MEX:FME N) has a DeferredTaxAndRevenue of MXN0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Fresenius Medical Care AG.
Is Fresenius Medical Care AG's DeferredTaxAndRevenue too high?
Fresenius Medical Care AG's current DeferredTaxAndRevenue is MXN0 Mil. Overall, Fresenius Medical Care AG has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's DeferredTaxAndRevenue compare to HCA and THC?
Fresenius Medical Care AG's DeferredTaxAndRevenue of MXN0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Fresenius Medical Care AG. Fresenius Medical Care AG's current DeferredTaxAndRevenue is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,670.07, compared to a current price of MXN778.14 — trading 53.4% below its estimated fair value. The current DeferredTaxAndRevenue is MXN0 Mil. Fresenius Medical Care AG's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current DeferredTaxAndRevenue is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of MXN778.14 is trading 53.4% below its estimated GF Value™ of MXN1,670.07. GuruFocus considers Fresenius Medical Care AG to be Significantly Undervalued.

Key valuation signals for MEX:FME N:

  • DeferredTaxAndRevenue: MXN0 Mil
  • GF Value™: MXN1,670.07 vs. price of MXN778.14 (53.4% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
48GF Score

Get the complete analysis for MEX:FME N

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN778.14
Price
MXN1,670.07
GF Value